Hello everyone, I’m taking over from my colleague Molly now. As always, feel free to get in touch if you have tips or updates to share, you can reach me on Twitter @JedySays or via email.
Summary of recent updates
I’m going to be handing over the blog to my colleague Jedidajah Otte shortly, but before I go, here’s a summary of recent developments in the coronavirus pandemic:
- Peru has suspended trials of China’s Sinopharm vaccine after a “serious adverse event” occurred with one of the volunteers for the study, the government has said.
- The head of the US FDA has insisted it is not rushing to approve a vaccine and that reports Donald Trump had forced him to do so by a certain date were false.
- Boris Johnson has told the UN’s virtual climate ambition summit of his commitment to climate action and the promise of green initiatives as a way to get people back into employment in the aftermath of the pandemic.
- There are not enough nurses to safely care for patients in the UK, according to the body that oversees the profession. The Royal College of Nursing said many of those working are suffering from anxiety and burnout after a gruelling nine months treating Covid patients.
- The British pharmaceutical company AstraZeneca has agreed to buy the US drugmaker Alexion for $39bn in cash and shares, in an attempt to bolster its work in immunology and rare diseases.
Thank you all for reading along. I hope you’re all safe and well.